Robyn Shea
Impact in
-
- Cell Adhesion Molecules Research
-
- Protease and Inhibitor Mechanisms
Papers in
-
- SARS-CoV-2 and COVID-19 Research 3
-
- Melanoma and MAPK Pathways 1
- Co-authors
- Stephen Weitz (1 shared paper)K Holli (1 shared paper)Tapio Visakorpi (1 shared paper)Olli Kallioniemi (1 shared paper)Jorma Isola (1 shared paper)Kevin Boyd (2 shared papers)Amit Sud (2 shared papers)Sharon West (2 shared papers)
- Journals
- Journal of Clinical Oncology (1 paper)The Lancet Haematology (1 paper)Annals of Clinical Biochemistry International Journal of Laboratory Medicine (1 paper)Transplantation and Cellular Therapy (1 paper)Bioorganic & Medicinal Chemistry Letters (1 paper)
- Partner nations
- United KingdomUnited StatesSweden
In The Last Decade
Robyn Shea
8 papers receiving 346 citations
Peers
Comparison fields: 5 of 62
- Immunology and Allergy 30
- Cancer Research 61
- Infectious Diseases 76
- Pathology and Forensic Medicine 59
- Oncology 89
Countries citing papers authored by Robyn Shea
This map shows the geographic impact of Robyn Shea's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robyn Shea with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robyn Shea more than expected).
Fields of papers citing papers by Robyn Shea
This network shows the impact of papers produced by Robyn Shea. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robyn Shea. The network helps show where Robyn Shea may publish in the future.
Co-authors
The 25 scholars most cited alongside Robyn Shea, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1993 | 100 | |
| 2 | 2021 | 75 | |
| 3 | 2006 | 71 | |
| 4 | 2014 | 52 | |
| 5 | 2016 | 25 | |
| 6 | 2021 | 24 | |
| 7 | 2018 | 4 | |
| 8 | 2021 | 2 |
About Robyn Shea
Robyn Shea is a scholar working on Infectious Diseases, Molecular Biology, Obstetrics and Gynecology, Pathology and Forensic Medicine and Social Psychology, having authored 8 papers that have together received 353 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (3 papers), COVID-19 Impact on Reproduction (2 papers), Vitamin C and Antioxidants Research (1 paper), Autism Spectrum Disorder Research (1 paper), Immunotherapy and Immune Responses (1 paper), Species Distribution and Climate Change (1 paper), Melanoma and MAPK Pathways (1 paper) and Plant and animal studies (1 paper). The work is most often cited by research in Immunology and Allergy (30 citations), Cancer Research (61 citations), Infectious Diseases (76 citations), Pathology and Forensic Medicine (59 citations) and Oncology (89 citations). Robyn Shea has collaborated with scholars based in United Kingdom, United States and Sweden. Frequent co-authors include Stephen Weitz, K Holli, Tapio Visakorpi, Olli Kallioniemi, Jorma Isola, Kevin Boyd, Amit Sud, Sharon West, Charlotte Pawlyn and Simon Stern. Their work appears in journals such as Journal of Clinical Oncology, The Lancet Haematology, Annals of Clinical Biochemistry International Journal of Laboratory Medicine, Transplantation and Cellular Therapy and Bioorganic & Medicinal Chemistry Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.